Aclaris Therapeutics’ drug fails in mid-stage study for skin disorder
March 6 (Reuters) - Aclaris Therapeutics Inc said on Monday its experimental drug failed to meet the main goal of a mid-stage study for the treatment of a type of known skin disorder as Hidradenitis Suppurativa. (Reporting by Raghav…